Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes
Abstract Streptococcus pneumoniae endophthalmitis is clinically more severe, more difficult to treat, and carry a higher risk of vision loss, evisceration, or enucleation. This study is to investigate the clinical settings, antibiotic susceptibility, and visual outcomes of S. pneumoniae endophthalmi...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea00e840fa674936ab484739558b24e1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ea00e840fa674936ab484739558b24e1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ea00e840fa674936ab484739558b24e12021-12-02T17:05:00ZStreptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes10.1038/s41598-021-85456-32045-2322https://doaj.org/article/ea00e840fa674936ab484739558b24e12021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85456-3https://doaj.org/toc/2045-2322Abstract Streptococcus pneumoniae endophthalmitis is clinically more severe, more difficult to treat, and carry a higher risk of vision loss, evisceration, or enucleation. This study is to investigate the clinical settings, antibiotic susceptibility, and visual outcomes of S. pneumoniae endophthalmitis at a tertiary referral center in Taiwan. S. pneumoniae endophthalmitis was diagnosed in 38 eyes of 38 patients. The main clinical features were postcataract endophthalmitis (n = 13, 34%) and endophthalmitis associated with corneal ulcer (n = 12, 32%), trauma (n = 6, 16%), endogenous etiology (n = 4, 11%), trabeculectomy (n = 2, 5%), and pterygium excision-related scleral ulcer (n = 1, 3%). Presenting visual acuity ranged from counting fingers to no light perception. Pars plana vitrectomy with intravitreal antibiotics was performed in 17 eyes (39%) in primary or secondary treatments. S. pneumoniae isolates were susceptible to vancomycin (38/38, 100%), penicillin (37/38, 97%), ceftriaxone (37/38, 97%), cefuroxime (12/15, 80%), levofloxacin (13/15 ,87%), and moxifloxacin (15/17, 88%). Final visual acuity was better than 20/400 in 3 of 38 eyes (8%), 5/200 to hand motions in 3 eyes (8%), and light perception to no light perception in 32 eyes (84%). Ten eyes (26%) underwent evisceration or enucleation. Although S. pneumoniae isolates were susceptible to vancomycin, S. pneumoniae endophthalmitis had a very poor visual prognosis.Kuan-Jen ChenYing-Jiun ChongMing-Hui SunHung-Chi ChenLaura LiuYen-Po ChenWei-Chi WuEugene Yu-Chuan KangChi-Chun LaiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Kuan-Jen Chen Ying-Jiun Chong Ming-Hui Sun Hung-Chi Chen Laura Liu Yen-Po Chen Wei-Chi Wu Eugene Yu-Chuan Kang Chi-Chun Lai Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes |
description |
Abstract Streptococcus pneumoniae endophthalmitis is clinically more severe, more difficult to treat, and carry a higher risk of vision loss, evisceration, or enucleation. This study is to investigate the clinical settings, antibiotic susceptibility, and visual outcomes of S. pneumoniae endophthalmitis at a tertiary referral center in Taiwan. S. pneumoniae endophthalmitis was diagnosed in 38 eyes of 38 patients. The main clinical features were postcataract endophthalmitis (n = 13, 34%) and endophthalmitis associated with corneal ulcer (n = 12, 32%), trauma (n = 6, 16%), endogenous etiology (n = 4, 11%), trabeculectomy (n = 2, 5%), and pterygium excision-related scleral ulcer (n = 1, 3%). Presenting visual acuity ranged from counting fingers to no light perception. Pars plana vitrectomy with intravitreal antibiotics was performed in 17 eyes (39%) in primary or secondary treatments. S. pneumoniae isolates were susceptible to vancomycin (38/38, 100%), penicillin (37/38, 97%), ceftriaxone (37/38, 97%), cefuroxime (12/15, 80%), levofloxacin (13/15 ,87%), and moxifloxacin (15/17, 88%). Final visual acuity was better than 20/400 in 3 of 38 eyes (8%), 5/200 to hand motions in 3 eyes (8%), and light perception to no light perception in 32 eyes (84%). Ten eyes (26%) underwent evisceration or enucleation. Although S. pneumoniae isolates were susceptible to vancomycin, S. pneumoniae endophthalmitis had a very poor visual prognosis. |
format |
article |
author |
Kuan-Jen Chen Ying-Jiun Chong Ming-Hui Sun Hung-Chi Chen Laura Liu Yen-Po Chen Wei-Chi Wu Eugene Yu-Chuan Kang Chi-Chun Lai |
author_facet |
Kuan-Jen Chen Ying-Jiun Chong Ming-Hui Sun Hung-Chi Chen Laura Liu Yen-Po Chen Wei-Chi Wu Eugene Yu-Chuan Kang Chi-Chun Lai |
author_sort |
Kuan-Jen Chen |
title |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes |
title_short |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes |
title_full |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes |
title_fullStr |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes |
title_full_unstemmed |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes |
title_sort |
streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ea00e840fa674936ab484739558b24e1 |
work_keys_str_mv |
AT kuanjenchen streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT yingjiunchong streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT minghuisun streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT hungchichen streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT lauraliu streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT yenpochen streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT weichiwu streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT eugeneyuchuankang streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes AT chichunlai streptococcuspneumoniaeendophthalmitisclinicalsettingsantibioticsusceptibilityandvisualoutcomes |
_version_ |
1718381823973654528 |